Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus.

Biochemical and biophysical research communications - 1 Sept 2006

Pan Ying, Zhang Jinkun, Zhou Ling, Zuo Jianmin, Zeng Yi

Abstract excerpt

Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is a high-incidence tumor in southern China. Latent membrane proteins 2 (LMP2) is a subdominant antigen of EBV. The present study was to develop a dendritic cells (DCs)-based cancer vaccine (rAd-LMP2-DC) and to study its biological characteristics and its immune functions. Our results showed that LMP2 gene transfer did not alter the typical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Shape

Share to Dendritic Cells

Share to Herpesvirus 4, Human

Share to Recombinant Proteins

Share to T-Lymphocytes

Share to Viral Matrix Proteins

Source

Identifiers

PMID: 16842756
DOI: 10.1016/j.bbrc.2006.05.214

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus.PMID 16842756Read ↗

Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4<sup>+</sup>- and CD8<sup>+</sup>-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal CarcinomaSemantic proximity Read ↗

In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant K-ras genes.Semantic proximity Read ↗

Glycyrrhiza uralensis polysaccharides as a Dendritic Cell-Based Vaccine Adjuvant: Enhanced Cancer Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read ↗

Glycyrrhiza uralensis polysaccharides as a DC-based Vaccine Adjuvant: Enhanced Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read ↗

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T CellsSemantic proximity Read ↗

SLC gene-modified dendritic cells mediate T cell-dependent anti-gastric cancer immune responses in vitro.Semantic proximity Read ↗

Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.Semantic proximity Read ↗

Generation of antitumor response by IL-2-transduced JAWS II dendritic cells.Semantic proximity Read ↗

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinomaSemantic proximity Read ↗

Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients.Semantic proximity Read ↗

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.Semantic proximity Read ↗

Dendritic Cells Cross-Present Latency Gene Products from Epstein-Barr Virus–Transformed B Cells and Expand Tumor-Reactive Cd8+ Killer T CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.